Patrick Plues

Washington, District of Columbia, United States
Patrick Plues has been involved with the biopharmaceutical industry for over twenty years and spans the breadth of the industry. He has worked in large fortune 100 biopharmaceutical companies to mid-sized specialty product companies and in industry trade organization.

Patrick started his career in the early 1990s working on Capitol Hill for United States Representative Robert Wise, a Democrat from West Virginia.

Patrick left Washington, DC in 1998 and moved to Philadelphia where he joined Wyeth Pharmaceuticals. He spent eleven years working in public affairs focused on state and federal legislative initiatives in women’s health, childhood and adult immunization, and new breakthrough biologic therapies. While at Wyeth, Patrick worked extensively with external third-party stakeholders including patient advocacy organizations, consumer groups and public policy think tanks. He also successfully managed Wyeth’s political action committee and employee grassroots program.

After Wyeth, Patrick became Director of Federal Government Affairs at Cephalon Inc., a specialty biopharmaceutical company headquartered outside of Philadelphia. In that role, he represented Cephalon’s interest during Congressional consideration of the Affordable Care Act. Patrick also managed federal health policy and reimbursement and third-party alliance development efforts at Cephalon.

In 2014, he joined the Biotechnology Innovation Organization (BIO) as Vice President for State Government Affairs. Patrick has responsibility for all state-level legislative advocacy efforts for BIO, which includes work in both healthcare and ag-biotech.

Patrick is a native of Irwin, Pennsylvania, which is in the Pittsburgh metropolitan area. He now resides north of Philadelphia in Bucks County, Pennsylvania. Patrick is a 1991 graduate of West Virginia University in Morgantown, WV.
Speaking In
[Available On-Demand]
Hear patient advocates discuss challenges and opportunities in bringing the patient voice to value…